Forward Pharma A/S Stock Forecast, Price & News

-0.09 (-1.39 %)
(As of 09/23/2021 11:10 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume196 shs
Average Volume190,202 shs
Market Capitalization$44.04 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

Forward Pharma A/S logo

About Forward Pharma A/S

Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.08 out of 5 stars

Medical Sector

1200th out of 1,352 stocks

Pharmaceutical Preparations Industry

586th out of 665 stocks

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

What stocks does MarketBeat like better than Forward Pharma A/S?

Wall Street analysts have given Forward Pharma A/S a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Forward Pharma A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Forward Pharma A/S?

Forward Pharma A/S saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 22,700 shares, a decrease of 27.2% from the August 15th total of 31,200 shares. Based on an average trading volume of 408,900 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.3% of the company's shares are sold short.
View Forward Pharma A/S's Short Interest

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.06.
View Forward Pharma A/S's earnings history

How has Forward Pharma A/S's stock been impacted by COVID-19?

Forward Pharma A/S's stock was trading at $5.55 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FWP shares have increased by 17.3% and is now trading at $6.51.
View which stocks have been most impacted by COVID-19

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the following people:
  • Claus Bo Svendsen, CEO & Principal Financial Officer
  • Thomas Carbone, Principal Accounting Officer

Who are some of Forward Pharma A/S's key competitors?

What other stocks do shareholders of Forward Pharma A/S own?

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

Who are Forward Pharma A/S's major shareholders?

Forward Pharma A/S's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BVF Inc. IL (7.67%), Morgan Stanley (2.64%) and Morgan Stanley (2.64%).

Which major investors are selling Forward Pharma A/S stock?

FWP stock was sold by a variety of institutional investors in the last quarter, including BVF Inc. IL.

Which major investors are buying Forward Pharma A/S stock?

FWP stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, and Morgan Stanley.

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $6.51.

How much money does Forward Pharma A/S make?

Forward Pharma A/S has a market capitalization of $44.87 million.

How many employees does Forward Pharma A/S have?

Forward Pharma A/S employs 4 workers across the globe.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is

Where are Forward Pharma A/S's headquarters?

Forward Pharma A/S is headquartered at OSTERGADE 24A 1, COPENHAGEN G7, 1100.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at (453) 344-4242 or via email at [email protected].

This page was last updated on 9/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.